Aryl Ureas With Angiogenisis Inhibiting Activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11932626

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER HEALTHCARE LLC100 BAYER BOULEVARD WHIPPANY NJ 07981

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dumas, Jacques Bethany, CT 108 2807
Elting, James Madison, CT 12 286
Hatoum-Makdad, Holia Hamden, CT 6 248
Scott, William J Guilford, CT 78 2469

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation